Daewon Pharmaceutical Statistics

Total Valuation

KRX:003220 has a market cap or net worth of KRW 286.57 billion. The enterprise value is 436.99 billion.

Market Cap	286.57B
Enterprise Value	436.99B

Important Dates

The next estimated earnings date is Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

KRX:003220 has 21.43 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	21.43M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	38.80%
Owned by Institutions (%)	13.09%
Float	12.84M

Valuation Ratios

The trailing PE ratio is 18.97 and the forward PE ratio is 6.83. KRX:003220's PEG ratio is 0.38.

PE Ratio	18.97
Forward PE	6.83
PS Ratio	0.48
PB Ratio	1.01
P/TBV Ratio	1.19
P/FCF Ratio	n/a
P/OCF Ratio	9.54
PEG Ratio	0.38

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.15, with an EV/FCF ratio of -90.49.

EV / Earnings	30.75
EV / Sales	0.73
EV / EBITDA	9.15
EV / EBIT	15.79
EV / FCF	-90.49

Financial Position

The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.66.

Current Ratio	1.19
Quick Ratio	0.62
Debt / Equity	0.66
Debt / EBITDA	4.00
Debt / FCF	-38.77
Interest Coverage	2.87

Financial Efficiency

Return on equity (ROE) is 3.68% and return on invested capital (ROIC) is 3.78%.

Return on Equity (ROE)	3.68%
Return on Assets (ROA)	3.06%
Return on Invested Capital (ROIC)	3.78%
Return on Capital Employed (ROCE)	6.97%
Revenue Per Employee	474.73M
Profits Per Employee	11.28M
Employee Count	1,260
Asset Turnover	1.10
Inventory Turnover	2.86

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.13% in the last 52 weeks. The beta is 0.47, so KRX:003220's price volatility has been lower than the market average.

Beta (5Y)	0.47
52-Week Price Change	-8.13%
50-Day Moving Average	13,891.80
200-Day Moving Average	14,621.45
Relative Strength Index (RSI)	45.60
Average Volume (20 Days)	39,677

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:003220 had revenue of KRW 598.16 billion and earned 14.21 billion in profits. Earnings per share was 656.02.

Revenue	598.16B
Gross Profit	285.97B
Operating Income	26.68B
Pretax Income	16.16B
Net Income	14.21B
EBITDA	46.77B
EBIT	26.68B
Earnings Per Share (EPS)	656.02

Full Income Statement

Balance Sheet

The company has 46.11 billion in cash and 187.24 billion in debt, giving a net cash position of -141.13 billion or -6,584.69 per share.

Cash & Cash Equivalents	46.11B
Total Debt	187.24B
Net Cash	-141.13B
Net Cash Per Share	-6,584.69
Equity (Book Value)	284.58B
Book Value Per Share	12,843.70
Working Capital	38.58B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 30.04 billion and capital expenditures -34.86 billion, giving a free cash flow of -4.83 billion.

Operating Cash Flow	30.04B
Capital Expenditures	-34.86B
Free Cash Flow	-4.83B
FCF Per Share	-225.31

Full Cash Flow Statement

Margins

Gross margin is 47.81%, with operating and profit margins of 4.46% and 2.38%.

Gross Margin	47.81%
Operating Margin	4.46%
Pretax Margin	2.70%
Profit Margin	2.38%
EBITDA Margin	7.82%
EBIT Margin	4.46%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 300.00, which amounts to a dividend yield of 2.25%.

Dividend Per Share	300.00
Dividend Yield	2.25%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	44.75%
Buyback Yield	-1.47%
Shareholder Yield	0.78%
Earnings Yield	4.96%
FCF Yield	-1.69%

Dividend Details

Stock Splits

The last stock split was on March 7, 2022. It was a forward split with a ratio of 1.03.

Last Split Date	Mar 7, 2022
Split Type	Forward
Split Ratio	1.03

Scores

KRX:003220 has an Altman Z-Score of 2.52. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.52
Piotroski F-Score	n/a